Journal of Experimental Medicine, ISSN 0022-1007, 08/2012, Volume 209, Issue 9, pp. 1537 - 1551
Splenic marginal zone lymphoma (SMZL) is a B cell malignancy of unknown pathogenesis, and thus an orphan of targeted therapies. By integrating whole-exome...
MEDICINE, RESEARCH & EXPERIMENTAL | B-CELL LYMPHOMA | HAJDU-CHENEY-SYNDROME | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENES | TRANSCRIPTIONAL REPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | VILLOUS LYMPHOCYTES | SWAP-70 CONTROLS | OF-FUNCTION MUTATIONS | IMMUNOLOGY | SOMATIC MUTATIONS | Lymphoma, B-Cell - metabolism | Signal Transduction | Humans | Splenic Neoplasms - genetics | Gene Expression Regulation, Neoplastic | Receptor, Notch2 - metabolism | Chromatin Assembly and Disassembly | Receptor, Notch2 - genetics | Lymphoma, B-Cell - genetics | Homeodomain Proteins - genetics | Exome | Splenic Neoplasms - pathology | NF-kappa B - genetics | Lymphoma, B-Cell - pathology | Splenic Neoplasms - metabolism | Polymorphism, Single Nucleotide | B-Lymphocytes - pathology | Mutation | Nuclear Proteins - genetics | Receptor, Notch1 - genetics | B-Lymphocytes - metabolism | 304
MEDICINE, RESEARCH & EXPERIMENTAL | B-CELL LYMPHOMA | HAJDU-CHENEY-SYNDROME | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENES | TRANSCRIPTIONAL REPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | VILLOUS LYMPHOCYTES | SWAP-70 CONTROLS | OF-FUNCTION MUTATIONS | IMMUNOLOGY | SOMATIC MUTATIONS | Lymphoma, B-Cell - metabolism | Signal Transduction | Humans | Splenic Neoplasms - genetics | Gene Expression Regulation, Neoplastic | Receptor, Notch2 - metabolism | Chromatin Assembly and Disassembly | Receptor, Notch2 - genetics | Lymphoma, B-Cell - genetics | Homeodomain Proteins - genetics | Exome | Splenic Neoplasms - pathology | NF-kappa B - genetics | Lymphoma, B-Cell - pathology | Splenic Neoplasms - metabolism | Polymorphism, Single Nucleotide | B-Lymphocytes - pathology | Mutation | Nuclear Proteins - genetics | Receptor, Notch1 - genetics | B-Lymphocytes - metabolism | 304
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 8, pp. 1403 - 1412
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehensive and dynamic prognostic algorithm including gene...
LONG-TERM | SURVIVAL | CLL | EVOLUTION | RISK GENOMIC ABERRATIONS | NOTCH1 MUTATIONS | FOLLOW-UP | GENETIC-CHARACTERIZATION | HEMATOLOGY | DETECTABLE CLONAL MOSAICISM | FLUDARABINE | Education, Medical, Continuing | Genetic Testing | Prognosis | Inhibitor of Apoptosis Proteins - genetics | Humans | Risk Factors | Kaplan-Meier Estimate | Myeloid Differentiation Factor 88 - genetics | RNA Splicing Factors | Male | Baculoviral IAP Repeat-Containing 3 Protein | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Phosphoproteins - genetics | Tumor Suppressor Protein p53 - genetics | Ubiquitin-Protein Ligases | Algorithms | DNA Mutational Analysis | Ribonucleoprotein, U2 Small Nuclear - genetics | Female | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Models, Genetic | Receptor, Notch1 - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Lymphoid Neoplasia | CME
LONG-TERM | SURVIVAL | CLL | EVOLUTION | RISK GENOMIC ABERRATIONS | NOTCH1 MUTATIONS | FOLLOW-UP | GENETIC-CHARACTERIZATION | HEMATOLOGY | DETECTABLE CLONAL MOSAICISM | FLUDARABINE | Education, Medical, Continuing | Genetic Testing | Prognosis | Inhibitor of Apoptosis Proteins - genetics | Humans | Risk Factors | Kaplan-Meier Estimate | Myeloid Differentiation Factor 88 - genetics | RNA Splicing Factors | Male | Baculoviral IAP Repeat-Containing 3 Protein | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Phosphoproteins - genetics | Tumor Suppressor Protein p53 - genetics | Ubiquitin-Protein Ligases | Algorithms | DNA Mutational Analysis | Ribonucleoprotein, U2 Small Nuclear - genetics | Female | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Models, Genetic | Receptor, Notch1 - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Lymphoid Neoplasia | CME
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 07/2011, Volume 208, Issue 7, pp. 1389 - 1401
The pathogenesis of chronic lymphocytic leukemia (CLL), the most common leukemia in adults, is still largely unknown. The full spectrum of genetic lesions that...
MULTIPLE-MYELOMA | MEDICINE, RESEARCH & EXPERIMENTAL | INDUCED CYTIDINE DEAMINASE | CELL LYMPHOMA | ACUTE LYMPHOBLASTIC-LEUKEMIA | GAMMA-SECRETASE INHIBITORS | TUMOR-SUPPRESSOR | IMMUNOLOGY | NF-KAPPA-B | T-ALL | PEST DOMAIN MUTATION | RICHTER-SYNDROME | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Gene Dosage | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Disease Progression | Genes, Immunoglobulin Heavy Chain | Drug Resistance, Neoplasm - genetics | Treatment Failure | Adult | Female | Aged | Polymorphism, Single Nucleotide | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Mutation | Genome, Human | Receptor, Notch1 - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
MULTIPLE-MYELOMA | MEDICINE, RESEARCH & EXPERIMENTAL | INDUCED CYTIDINE DEAMINASE | CELL LYMPHOMA | ACUTE LYMPHOBLASTIC-LEUKEMIA | GAMMA-SECRETASE INHIBITORS | TUMOR-SUPPRESSOR | IMMUNOLOGY | NF-KAPPA-B | T-ALL | PEST DOMAIN MUTATION | RICHTER-SYNDROME | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Gene Dosage | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Disease Progression | Genes, Immunoglobulin Heavy Chain | Drug Resistance, Neoplasm - genetics | Treatment Failure | Adult | Female | Aged | Polymorphism, Single Nucleotide | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Mutation | Genome, Human | Receptor, Notch1 - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
Journal Article
Blood, ISSN 0006-4971, 01/2012, Volume 119, Issue 2, pp. 521 - 529
Analysis of the chronic lymphocytic leukemia (CLL) coding genome has recently disclosed that the NOTCH1 proto-oncogene is recurrently mutated at CLL...
DIAGNOSIS | PROGNOSTIC-FACTORS | PERSPECTIVES | HAZARDS REGRESSION-MODEL | TP53 MUTATIONS | INDEX | NATURAL-HISTORY | HEMATOLOGY | RICHTER-SYNDROME | UNTREATED PATIENTS | B-CLL | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Male | Survival Rate | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Mutation - genetics | Disease Progression | Tumor Suppressor Protein p53 - genetics | Cell Transformation, Neoplastic | Female | Immunoglobulin Variable Region - genetics | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Receptor, Notch1 - genetics | Chromosomes, Human, Pair 12 - genetics | Immunoglobulin Heavy Chains - genetics | Lymphoid Neoplasia | Clinical Trials and Observations
DIAGNOSIS | PROGNOSTIC-FACTORS | PERSPECTIVES | HAZARDS REGRESSION-MODEL | TP53 MUTATIONS | INDEX | NATURAL-HISTORY | HEMATOLOGY | RICHTER-SYNDROME | UNTREATED PATIENTS | B-CLL | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Male | Survival Rate | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Mutation - genetics | Disease Progression | Tumor Suppressor Protein p53 - genetics | Cell Transformation, Neoplastic | Female | Immunoglobulin Variable Region - genetics | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Receptor, Notch1 - genetics | Chromosomes, Human, Pair 12 - genetics | Immunoglobulin Heavy Chains - genetics | Lymphoid Neoplasia | Clinical Trials and Observations
Journal Article
2005, Current topics in microbiology and immunology, ISBN 3540252797, Volume 294., vi, 189
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. It is also the prototype of B-cell chronic lymphoid malignancies and of...
Lymphocytic leukemia | Hematology | Cancer Research | Biomedicine
Lymphocytic leukemia | Hematology | Cancer Research | Biomedicine
Book
Nature Reviews Immunology, ISSN 1474-1733, 03/2015, Volume 15, Issue 3, pp. 172 - 184
Germinal centres (GCs) are involved in the selection of B cells secreting high-affinity antibodies and are also the origin of most human B cell lymphomas....
CHROMOSOMAL TRANSLOCATIONS | BURKITT-LYMPHOMA | SECRETING PLASMA-CELLS | C-MYC | NON-HODGKIN-LYMPHOMA | CLASS-SWITCH RECOMBINATION | FOLLICULAR LYMPHOMA | IMMUNOLOGY | DEREGULATED BCL6 EXPRESSION | NF-KAPPA-B | TRANSCRIPTION FACTOR | Lymphoma, Follicular - metabolism | Lymphoma, B-Cell - metabolism | B-Lymphocytes - immunology | Signal Transduction | Cell Transformation, Neoplastic | Germinal Center - immunology | Humans | Antibody Affinity | Burkitt Lymphoma - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | Oncology, Experimental | Development and progression | Lymphomas | Genetic aspects | B cells | Research | Properties | Cancer
CHROMOSOMAL TRANSLOCATIONS | BURKITT-LYMPHOMA | SECRETING PLASMA-CELLS | C-MYC | NON-HODGKIN-LYMPHOMA | CLASS-SWITCH RECOMBINATION | FOLLICULAR LYMPHOMA | IMMUNOLOGY | DEREGULATED BCL6 EXPRESSION | NF-KAPPA-B | TRANSCRIPTION FACTOR | Lymphoma, Follicular - metabolism | Lymphoma, B-Cell - metabolism | B-Lymphocytes - immunology | Signal Transduction | Cell Transformation, Neoplastic | Germinal Center - immunology | Humans | Antibody Affinity | Burkitt Lymphoma - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | Oncology, Experimental | Development and progression | Lymphomas | Genetic aspects | B cells | Research | Properties | Cancer
Journal Article
Seminars in Hematology, ISSN 0037-1963, 04/2015, Volume 52, Issue 2, pp. 67 - 76
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in the western world, is an aggressive disease that remains incurable in...
CYTIDINE DEAMINASE AID | CLASS SWITCH RECOMBINATION | SOMATIC HYPERMUTATION | BCL6 | NEGATIVE AUTOREGULATION | FOLLICULAR LYMPHOMA | HODGKIN-LYMPHOMA | MUTATIONS | HEMATOLOGY | NF-KAPPA-B | GERMINAL-CENTER | B-Lymphocytes - immunology | Lymphocyte Activation | Genomics | Humans | Cell Differentiation | B-Lymphocytes - pathology | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics
CYTIDINE DEAMINASE AID | CLASS SWITCH RECOMBINATION | SOMATIC HYPERMUTATION | BCL6 | NEGATIVE AUTOREGULATION | FOLLICULAR LYMPHOMA | HODGKIN-LYMPHOMA | MUTATIONS | HEMATOLOGY | NF-KAPPA-B | GERMINAL-CENTER | B-Lymphocytes - immunology | Lymphocyte Activation | Genomics | Humans | Cell Differentiation | B-Lymphocytes - pathology | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 03/2016, Volume 16, Issue 3, pp. 145 - 162
Recent investigations have provided an increasingly complete picture of the genetic landscape of chronic lymphocytic leukaemia (CLL). These analyses revealed...
BRUTONS TYROSINE KINASE | ONCOLOGY | NOTCH1 MUTATIONS | DOWN-REGULATION | TUMOR-SUPPRESSOR | CELL RECEPTOR | TP53 MUTATIONS | SF3B1 MUTATIONS | NF-KAPPA-B | GENOME-WIDE ASSOCIATION | CLINICAL-SIGNIFICANCE | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Humans | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Molecular targeted therapy | Chronic lymphocytic leukemia | Innovations | Development and progression | Genotype | Genetic aspects | Gene expression | Identification and classification | Health aspects
BRUTONS TYROSINE KINASE | ONCOLOGY | NOTCH1 MUTATIONS | DOWN-REGULATION | TUMOR-SUPPRESSOR | CELL RECEPTOR | TP53 MUTATIONS | SF3B1 MUTATIONS | NF-KAPPA-B | GENOME-WIDE ASSOCIATION | CLINICAL-SIGNIFICANCE | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Humans | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Molecular targeted therapy | Chronic lymphocytic leukemia | Innovations | Development and progression | Genotype | Genetic aspects | Gene expression | Identification and classification | Health aspects
Journal Article
Immunological Reviews, ISSN 0105-2896, 05/2012, Volume 247, Issue 1, pp. 172 - 183
BCL6 is a transcriptional repressor required in mature B cells during the germinal center (GC) reaction. Multiple mechanisms act coordinately to timely...
B‐cell differentiation | non‐Hodgkin B‐cell lymphoma | germinal center | BCL6 | DNA damage response | TP53 | B-cell differentiation | Non-Hodgkin B-cell lymphoma | Germinal center | SOMATIC HYPERMUTATION | FINGER ENCODING GENE | AFFECTING BAND 3Q27 | IMMUNOLOGY | non-Hodgkin B-cell lymphoma | PLASMA-CELLS | RUBINSTEIN-TAYBI SYNDROME | IN-VIVO | NEGATIVE AUTOREGULATION | PROLYL ISOMERASE PIN1 | NON-HODGKINS-LYMPHOMA | TRANSCRIPTION FACTOR | Proto-Oncogene Proteins c-bcl-6 - genetics | B-Lymphocytes - cytology | Animals | Humans | Proto-Oncogene Proteins c-bcl-6 - metabolism | Transcriptional Activation | Cell Differentiation | B-Lymphocytes - pathology | Germinal Center - pathology | Cell Transformation, Neoplastic - pathology | Germinal Center - cytology | Lymphoma, Non-Hodgkin - physiopathology | Immunoglobulins | Lymphomas | Genetic transcription | Tumor proteins | DNA | Genes | Post-transcription | Transformation | Transcription | DNA damage | Lymphoma | Cell activation | Germinal centers | Lymphocytes B | Repressors | Differentiation | Oncogenes | Bcl-6 protein
B‐cell differentiation | non‐Hodgkin B‐cell lymphoma | germinal center | BCL6 | DNA damage response | TP53 | B-cell differentiation | Non-Hodgkin B-cell lymphoma | Germinal center | SOMATIC HYPERMUTATION | FINGER ENCODING GENE | AFFECTING BAND 3Q27 | IMMUNOLOGY | non-Hodgkin B-cell lymphoma | PLASMA-CELLS | RUBINSTEIN-TAYBI SYNDROME | IN-VIVO | NEGATIVE AUTOREGULATION | PROLYL ISOMERASE PIN1 | NON-HODGKINS-LYMPHOMA | TRANSCRIPTION FACTOR | Proto-Oncogene Proteins c-bcl-6 - genetics | B-Lymphocytes - cytology | Animals | Humans | Proto-Oncogene Proteins c-bcl-6 - metabolism | Transcriptional Activation | Cell Differentiation | B-Lymphocytes - pathology | Germinal Center - pathology | Cell Transformation, Neoplastic - pathology | Germinal Center - cytology | Lymphoma, Non-Hodgkin - physiopathology | Immunoglobulins | Lymphomas | Genetic transcription | Tumor proteins | DNA | Genes | Post-transcription | Transformation | Transcription | DNA damage | Lymphoma | Cell activation | Germinal centers | Lymphocytes B | Repressors | Differentiation | Oncogenes | Bcl-6 protein
Journal Article
Nature Reviews Immunology, ISSN 1474-1733, 01/2008, Volume 8, Issue 1, pp. 22 - 33
Over the past several years, studies on normal and malignant B cells have provided new insights into the unique physiology of the germinal centre (GC). In...
ACTIVATION-INDUCED DEAMINASE | CYTIDINE DEAMINASE AID | SOMATIC HYPERMUTATION | SECRETING PLASMA-CELLS | IN-VIVO | ANTIGEN-DRIVEN SELECTION | ANTIBODY DIVERSIFICATION ENZYME | CLASS-SWITCH RECOMBINATION | SINGLE-STRANDED-DNA | IMMUNOLOGY | TRANSCRIPTION FACTOR | Cell Differentiation - immunology | B-Lymphocytes - cytology | Animals | B-Lymphocytes - immunology | Germinal Center - immunology | Humans | Lymphoma, B-Cell - physiopathology | Lymphoma, B-Cell - immunology | Genetic aspects | Research | Non-Hodgkin's lymphomas | B cells | Gene expression | Health aspects | Risk factors
ACTIVATION-INDUCED DEAMINASE | CYTIDINE DEAMINASE AID | SOMATIC HYPERMUTATION | SECRETING PLASMA-CELLS | IN-VIVO | ANTIGEN-DRIVEN SELECTION | ANTIBODY DIVERSIFICATION ENZYME | CLASS-SWITCH RECOMBINATION | SINGLE-STRANDED-DNA | IMMUNOLOGY | TRANSCRIPTION FACTOR | Cell Differentiation - immunology | B-Lymphocytes - cytology | Animals | B-Lymphocytes - immunology | Germinal Center - immunology | Humans | Lymphoma, B-Cell - physiopathology | Lymphoma, B-Cell - immunology | Genetic aspects | Research | Non-Hodgkin's lymphomas | B cells | Gene expression | Health aspects | Risk factors
Journal Article